PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
Clinical trial NCT06059469 · RECRUITING
Trial details
- NCT number
- NCT06059469
- Sponsor
- Jules Bordet Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2025-06-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.